RIL
CSTL icon

Rothschild Investment LLC’s Castle Biosciences CSTL Stock Holding History

Rothschild Investment LLC’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.29K Sell
54
-4
-7% -$89 ﹤0.01% 2948
2026
Q1 		$1.42K Buy
58
+5
+9% +$164 ﹤0.01% 2721
2025
Q4 		$2.06K Sell
53
-2
-4% -$64 ﹤0.01% 2355
2025
Q3 		$1.25K Sell
55
-30
-35% -$609 ﹤0.01% 2496
2025
Q2 		$1.74K Buy
85
+65
+325% +$1.2K ﹤0.01% 2163
2025
Q1 		$400 Sell
20
-20
-50% -$495 ﹤0.01% 2687
2024
Q4 		$1.07K Buy
40
+5
+14% +$152 ﹤0.01% 2177
2024
Q3 		$998 Buy
35
+20
+133% +$509 ﹤0.01% 2170
2024
Q2 		$327 Buy
+15
New +$334 ﹤0.01% 2251

Other funds holding CSTL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Rothschild Investment LLC's CSTL Position: Q2 2026 in Review

Rothschild Investment LLC reduced its Castle Biosciences (CSTL) stake by 6.9% in Q2 2026, selling an estimated $89 and leaving 54 shares worth $1.29K. The position accounts for ﹤0.01% of the portfolio, ranked #2948.

Rothschild Investment LLC first reported a position in CSTL in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.06K in Q4 2025. 61 funds tracked by Wall St. Rank hold CSTL as of Q2 2026.

  • Rothschild Investment LLC held 54 shares of Castle Biosciences worth $1.29K as of Q2 2026.
  • Rothschild Investment LLC sold 4 Castle Biosciences shares in Q2 2026, an estimated $89.
  • Castle Biosciences made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2948 holding.
  • Rothschild Investment LLC first reported a position in Castle Biosciences in Q2 2024 and has held it in 9 quarters since.
  • Rothschild Investment LLC's Castle Biosciences position peaked at $2.06K in Q4 2025.
  • 61 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.